Literature DB >> 7743823

Multiple dose regimens. Impact on compliance.

D P Tashkin1.   

Abstract

Mesh:

Substances:

Year:  1995        PMID: 7743823     DOI: 10.1378/chest.107.5_supplement.176s

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


× No keyword cloud information.
  12 in total

1.  Acute supra-therapeutic oral terbutaline administration has no ergogenic effect in non-asthmatic athletes.

Authors:  Anthony M J Sanchez; Fabio Borrani; Marie Amélie Le Fur; Anais Le Mieux; Virgile Lecoultre; Guillaume Py; Christophe Gernigon; Katia Collomp; Robin Candau
Journal:  Eur J Appl Physiol       Date:  2012-07-06       Impact factor: 3.078

2.  The association of weight with the detection of airflow obstruction and inhaled treatment among patients with a clinical diagnosis of COPD.

Authors:  Bridget F Collins; David Ramenofsky; David H Au; Jun Ma; Jane E Uman; Laura C Feemster
Journal:  Chest       Date:  2014-12       Impact factor: 9.410

Review 3.  Patient adherence in COPD.

Authors:  J Bourbeau; S J Bartlett
Journal:  Thorax       Date:  2008-09       Impact factor: 9.139

4.  Intermittent intravenous ibandronate injections reduce vertebral fracture risk in corticosteroid-induced osteoporosis: results from a long-term comparative study.

Authors:  J D Ringe; A Dorst; H Faber; K Ibach; F Sorenson
Journal:  Osteoporos Int       Date:  2003-08-28       Impact factor: 4.507

Review 5.  Inhaled treatment for chronic obstructive pulmonary disease: what's new and how does it fit?

Authors:  G P Currie; B J Lipworth
Journal:  QJM       Date:  2015-11-11

6.  Relationships between repeated instruction on inhalation therapy, medication adherence, and health status in chronic obstructive pulmonary disease.

Authors:  Masaya Takemura; Katsumi Mitsui; Ryo Itotani; Manabu Ishitoko; Shinko Suzuki; Masataka Matsumoto; Kensaku Aihara; Tsuyoshi Oguma; Tetsuya Ueda; Hitoshi Kagioka; Motonari Fukui
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2011-01-20

7.  Efficacy and safety of a multifactor intervention to improve therapeutic adherence in patients with chronic obstructive pulmonary disease (COPD): protocol for the ICEPOC study.

Authors:  Pilar Barnestein-Fonseca; José Leiva-Fernández; Francisca Vidal-España; Antonio García-Ruiz; Daniel Prados-Torres; Francisca Leiva-Fernández
Journal:  Trials       Date:  2011-02-14       Impact factor: 2.279

Review 8.  Patient considerations in the treatment of COPD: focus on the new combination inhaler umeclidinium/vilanterol.

Authors:  Timothy E Albertson; Richart Harper; Susan Murin; Christian Sandrock
Journal:  Patient Prefer Adherence       Date:  2015-02-02       Impact factor: 2.711

9.  Managing patient adherence and quality of life in epilepsy.

Authors:  Joanne Eatock; Gus A Baker
Journal:  Neuropsychiatr Dis Treat       Date:  2007-02       Impact factor: 2.570

Review 10.  Switching treatments in COPD: implications for costs and treatment adherence.

Authors:  Fulvio Braido; Federico Lavorini; Francesco Blasi; Ilaria Baiardini; Giorgio Walter Canonica
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-12-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.